Phase I trial of subretinal injection of a recombinant adeno-associated virus (rAAV2-VMD2-hMERTK) gene vector to patients with MERTK RP
Purpose: To report short-term safety results of the phase I trial of subretinal injection of a rAAV2-VMD2-hMERTK gene vector for retinitis pigmentosa (RP) secondary to the MERTK Mutation Methods: Except in one patient, the worst seeing eye of patients with MERTK mutation proven RP was injected with...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , |
| Format: | article |
| Published: |
2013
|
| Online Access: | http://hdl.handle.net/10725/10895 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://iovs.arvojournals.org/article.aspx?articleid=2151443 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|